Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer: The FFCD PRODIGE 13 randomised phase III trial

Digestive and Liver Disease

Volumn 47, Issue 7, 2015, Pages 529-531

  Lepage, Côme ^a   Phelip, Jean Marc ^c   Cany, Laurent ^d   Faroux, Roger ^f   Manfredi, Sylvain ^e   Ain, Jean Francois ^k   Pezet, Denis ^g   Baconnier, Mathieu ^l   Deguiral, Philippe ^h   Terrebone, Eric ⁱ   Adenis, Antoine ^j   Le Malicot, Karine ^a   Bedenne, Laurent ^a   Bouché, Olivier ^b  

^a INSERM   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^d CHG Perigueux   (France)

^e RENNES UNIVERSITY HOSPITAL   (France)

^f Service d'urologie   (France)

^g UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^h CHG St Nazaire   (France)

ⁱ CH Pessac   (France)

^j CENTRE OSCAR LAMBRET   (France)

^k Private Hospital   (France)

^l Gastroenterology   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

CANCER ADJUVANT THERAPY; CANCER RECURRENCE; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EDITORIAL; FOLLOW UP; HUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL RATE; THORAX RADIOGRAPHY; ADULT; AGED; BLOOD; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; CLINICAL PROTOCOLS; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84937639015     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2015.03.021     Document Type: Editorial

References (21)

1. Chauvenet M., Lepage C., Jooste V., et al. Prevalence of patients with colorectal cancer requiring follow-up or active treatment. European Journal of Cancer 2009, 45:1460-1465.
2. Faivre-Finn C., Bouvier-Benhamiche A.M., Phelip J.M., et al. Colon cancer in France: evidence for improvement in management and survival. Gut 2002, 51:60-64.
3. Finn-Faivre C., Maurel J., Benhamiche A.M., et al. Evidence of improving survival of patients with rectal cancer in France: a population based study. Gut 1999, 44:377-381.
4. Lepage C., Bouvier A.M., Binquet C., et al. Are the recommendations of the French consensus conference on the management of colon cancer followed up. European Journal of Cancer Prevention 2006, 15:295-300.
5. Manfredi S., Bouvier A.M., Lepage C., et al. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. British Journal of Surgery 2006, 93:1115-1122.
6. Manfredi S., Benhamiche A.M., Meny B., et al. Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer. British Journal of Surgery 2001, 88:1221-1227.
7. Lecomte T., Andre T., Bibeau F., et al. Cancer du côlon. Thésaurus National de Cancérologie Digestive 2011, July, http://www.tncd.org [online].
8. Figueredo A., Rumble R.B., Maroun J., et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003, 3:26.
9. Renehan A.G., Egger M., Saunders M.P., et al. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002, 324:813.
10. Makela J.T., Laitinen S.O., Kairaluoma M.I. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Archives of Surgery 1995, 130:1062-1067.
11. Schoemaker D., Black R., Giles L., et al. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998, 114:7-14.
12. Jeffery G.M., Hickey B.E., Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database of Systematic Reviews 2002, CD002200.
13. Glover C., Douse P., Kane P., et al. Accuracy of investigations for asymptomatic colorectal liver metastases. Diseases of the Colon and Rectum 2002, 45:476-484.
14. Goldberg R.M., Fleming T.R., Tangen C.M., et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Annals of Internal Medicine 1998, 129:27-35.
15. Peuchot M., Libshitz H.I. Pulmonary metastatic disease: radiologic-surgical correlation. Radiology 1987, 164:719-722.
16. Conférence de Consensus Prévention, dépistage et prise en charge des cancers du côlon. Gastroentérologie Clinique et Biologique 1998, 22:S275-S288.
17. Northover J., Houghton J., Lennon T. CEA to detect recurrence of colon cancer. JAMA 1994, 272:31.
18. Wichmann M.W., Lau-Werner U., Muller C., et al. Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer. Anticancer Research 2000, 20:4953-4955.
19. Desch C.E., Benson A.B., Somerfield M.R., et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. Journal of Clinical Oncology 2005, 23:8512-8519.
20. O'Brien P.C., Fleming T.R. A multiple testing procedure for clinical trials. Biometrics 1979, 35:549-556.
21. Lan K.K.G., DeMets D.L. Discrete sequential boundaries for clinical trials. Biometrika 1983, 70(3):659-663.